Published in Clin Res Cardiol on May 15, 2014
Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation. Clin Res Cardiol (2015) 1.05
Cardioversion of atrial fibrillation or atrial flutter into sinus rhythm reduces nocturnal central respiratory events and unmasks obstructive sleep apnoea. Clin Res Cardiol (2015) 0.89
Atrial fibrillation and long-term sports practice: epidemiology and mechanisms. Clin Res Cardiol (2014) 0.79
Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database. Vasc Health Risk Manag (2015) 0.75
Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalized in France. Europace (2015) 0.75
Prognosis in patients with atrial fibrillation and a presumed "temporary cause" in a community-based cohort study. Clin Res Cardiol (2016) 0.75
Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre. Clin Res Cardiol (2015) 0.75
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med (1994) 10.26
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace (2010) 6.31
Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J (2005) 4.46
Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med (2010) 4.15
Bias. J Epidemiol Community Health (2004) 3.85
Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation. Stroke (2000) 2.29
Failure to renew prescriptions for gastroprotective agents to patients on continuous nonsteroidal anti-inflammatory drugs increases rate of upper gastrointestinal injury. Clin Gastroenterol Hepatol (2013) 2.02
Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study). Eur Heart J (2006) 1.91
The use of anticoagulants in the management of atrial fibrillation among general practices in England. Heart (2013) 1.90
New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation (2001) 1.83
Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation (2005) 1.66
Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry. Clin Res Cardiol (2011) 1.58
Risk factors for incident atrial fibrillation with and without left atrial enlargement in women. Int J Cardiol (2013) 1.57
Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials. Eur Heart J (2006) 1.55
Obesity is a risk factor for atrial fibrillation among fertile young women: a nationwide cohort study. Europace (2013) 1.51
Patients with atrial fibrillation in a primary care setting: Val-FAAP study. Rev Esp Cardiol (Engl Ed) (2011) 1.46
Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis. Osteoporos Int (2009) 1.39
Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation. JAMA (2012) 1.36
Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark. Br J Clin Pharmacol (2002) 1.08
Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia. World J Urol (2011) 0.98
Differences and time trends in drug treatment of atrial fibrillation in men and women and doctors' adherence to warfarin therapy recommendations: a Swedish study of prescribed drugs in primary care in 2002 and 2007. Eur J Clin Pharmacol (2012) 0.92
Women with atrial fibrillation: Greater risk, less attention. Gend Med (2009) 0.91
Epidemiology of atrial fibrillation in France: extrapolation of international epidemiological data to France and analysis of French hospitalization data. Arch Cardiovasc Dis (2011) 0.89
Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents. Europace (2012) 0.84
Characteristics and management of outpatients with history of or current atrial fibrillation: the observational French EPHA study. Arch Cardiovasc Dis (2010) 0.84
Do women bleed more than men when prescribed novel oral anticoagulants for venous thromboembolism? A sex-based meta-analysis. Thromb Res (2013) 0.84
Preventing stroke in people with atrial fibrillation: a cross-sectional study. J Public Health (Oxf) (2004) 0.81
Health problems most commonly diagnosed among young female patients during visits to general practitioners and gynecologists in France before the initiation of the human papillomavirus vaccination program. Pharmacoepidemiol Drug Saf (2011) 0.80
Frequency and risk factors for under- and over-treatment in stroke prevention for patients with non-valvular atrial fibrillation in general practice. PLoS One (2013) 0.79
Epidemiologic Evaluation of Cardiovascular Risk in Patients Receiving Milnacipran, Venlafaxine, or Amitriptyline: Evidence from French Health Data. Ann Pharmacother (2011) 0.75
Stroke prevention for patients with atrial fibrillation: improving but not perfect yet. Heart (2013) 0.75
Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection. Am J Gastroenterol (2005) 2.62
Candida as a risk factor for mortality in peritonitis. Crit Care Med (2006) 2.07
Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study. Eur J Heart Fail (2006) 1.45
Characterization of distinct mesenchymal-like cell populations from human skeletal muscle in situ and in vitro. Exp Cell Res (2010) 1.04
Human bone marrow mesenchymal stem cells: a systematic reappraisal via the genostem experience. Stem Cell Rev (2011) 0.95
Administrative complexities for a European observational study despite directives harmonising requirements. Pharmacoepidemiol Drug Saf (2012) 0.93
Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): the multinational case-population SALT study. Drug Saf (2013) 0.88
Roles and practices of general practitioners and psychiatrists in management of depression in the community. BMC Fam Pract (2006) 0.88
Concordance between prescriber- and patient-reported previous medical history and NSAID indication in the CADEUS cohort. Pharmacoepidemiol Drug Saf (2010) 0.87
Usage patterns of 'over-the-counter' vs. prescription-strength nonsteroidal anti-inflammatory drugs in France. Br J Clin Pharmacol (2014) 0.86
The F508del mutation in cystic fibrosis transmembrane conductance regulator gene impacts bone formation. Am J Pathol (2012) 0.85
Methodology for a multinational case-population study on liver toxicity risks with NSAIDs: the Study of Acute Liver Transplant (SALT). Eur J Clin Pharmacol (2012) 0.85
One-year effectiveness of a 3-week balneotherapy program for the treatment of overweight or obesity. Evid Based Complement Alternat Med (2012) 0.84
Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France. Pharmacoepidemiol Drug Saf (2012) 0.82
Impact of prescriber nonresponse on patient representativeness. Epidemiology (2008) 0.82
The CADEUS study: burden of nonsteroidal anti-inflammatory drug (NSAID) utilization for musculoskeletal disorders in blue collar workers. Br J Clin Pharmacol (2009) 0.81
Contribution of modeling approaches and virtual populations in transposing the results of clinical trials into real life and in enlightening public health decisions. Therapie (2012) 0.81
Collagen supramolecular and suprafibrillar organizations on osteoblasts long-term behavior: benefits for bone healing materials. J Biomed Mater Res A (2010) 0.80
Use of health insurance claim patterns to identify patients using nonsteroidal anti-inflammatory drugs for rheumatoid arthritis. Pharmacoepidemiol Drug Saf (2012) 0.78
High rate of adefovir-lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: results of a national survey in 1730 patients. Eur J Gastroenterol Hepatol (2010) 0.77
Are traditional NSAIDs prescribed appropriately among French elderly with osteoarthritis? Results from the CADEUS cohort. Eur J Clin Pharmacol (2011) 0.77
Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users. Br J Clin Pharmacol (2010) 0.77
Patients' perspectives on residual symptoms in bipolar disorder: a focus group study. J Nerv Ment Dis (2014) 0.77
Are there risk factors for musculoskeletal procedural pain? A national prospective multicentre study of procedural instantaneous pain and its recall after knee and spine injections. Joint Bone Spine (2011) 0.77
Cardiovascular risks associated with low-dose ibuprofen and diclofenac as used OTC. Expert Opin Drug Saf (2013) 0.76
The EULEV cohort study: rates of and factors associated with continuation of levetiracetam after 1 year. Br J Clin Pharmacol (2011) 0.75
Are joint and soft tissue injections painful? Results of a national French cross-sectional study of procedural pain in rheumatological practice. BMC Musculoskelet Disord (2010) 0.75
Is paracetamol hepatotoxic at normal doses? BMJ (2013) 0.75
[Implication of the ubiquitin ligase c-Cbl in bone formation and tumorigenesis]. Med Sci (Paris) (2012) 0.75
[In Process Citation]. Therapie (2012) 0.75
Estimating the yearly number of eyes with treatable neovascular age-related macular degeneration using a direct standardization method and a markov model. Invest Ophthalmol Vis Sci (2006) 0.75
Audience noise in concert halls during musical performances. J Acoust Soc Am (2012) 0.75
Relative risks from case-population data. Epidemiology (2013) 0.75
Pharmacoepidemiology studies: what levels of evidence and how can they be reached? Therapie (2013) 0.75
Bone remodeling: facts and perspectives. Arch Biochem Biophys (2008) 0.75